Predictions
Nektar Therapeutics
Start price
Target price
Perf. (%)
€49.91
21.11.17
21.11.17
€55.00
29.12.17
29.12.17
21.22%
29.12.17
29.12.17
Nektar Therapeutics
Start price
Target price
Perf. (%)
€45.02
21.11.17
21.11.17
€49.61
29.12.17
29.12.17
21.22%
29.12.17
29.12.17
IQVIA Holdings Inc.
Start price
Target price
Perf. (%)
€93.50
21.11.17
21.11.17
€97.42
22.05.18
22.05.18
0.00%
22.05.18
22.05.18
IQVIA Holdings Inc.
Start price
Target price
Perf. (%)
€103.66
21.11.17
21.11.17
€108.00
22.05.18
22.05.18
0.00%
22.05.18
22.05.18
Aralez Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€1.36
21.11.17
21.11.17
€2.26
21.05.18
21.05.18
-72.81%
21.05.18
21.05.18
Johnson & Johnson
Start price
Target price
Perf. (%)
€125.49
21.11.17
21.11.17
€135.30
06.08.18
06.08.18
-3.54%
06.08.18
06.08.18
Could be worthwhile Investment >10% per year
Market Leader or Top 3
Known brand
Future proof or reliable business model
GW Pharmaceuticals plc ADR
Start price
Target price
Perf. (%)
€111.71
21.11.17
21.11.17
€117.26
14.12.17
14.12.17
5.47%
14.12.17
14.12.17
GW Pharmaceuticals plc ADR
Start price
Target price
Perf. (%)
€123.85
21.11.17
21.11.17
€130.00
14.12.17
14.12.17
5.47%
14.12.17
14.12.17
Aimmune Therapeutics Inc
Start price
Target price
Perf. (%)
€31.58
20.11.17
20.11.17
€36.08
01.01.19
01.01.19
-31.68%
01.01.19
01.01.19
Carisma Therapeutics Inc.
Start price
Target price
Perf. (%)
€13.35
19.11.17
19.11.17
€21.65
03.01.18
03.01.18
16.91%
03.01.18
03.01.18
Could be worthwhile Investment >10% per year
Trillium Therapeutics
Start price
Target price
Perf. (%)
€8.70
18.11.17
18.11.17
€13.08
18.05.18
18.05.18
-37.82%
18.05.18
18.05.18
BioLine RX Ltd ADR
Start price
Target price
Perf. (%)
€219.19
18.11.17
18.11.17
€304.43
18.05.18
18.05.18
-14.59%
18.05.18
18.05.18
Could be worthwhile Investment >10% per year
Teva Pharmaceutical Industries Ltd ADR
Start price
Target price
Perf. (%)
€12.47
18.11.17
18.11.17
€18.04
06.12.17
06.12.17
5.87%
06.12.17
06.12.17
Chugai Pharmaceutical Co Ltd
Start price
Target price
Perf. (%)
€14.75
17.11.17
17.11.17
€16.00
08.12.17
08.12.17
8.68%
08.12.17
08.12.17
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€113.81
16.11.17
16.11.17
€126.28
12.03.18
12.03.18
11.75%
12.03.18
12.03.18
Could be worthwhile Investment >10% per year